These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17361343)

  • 41. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.
    Kogure D; Matsuda H; Ohnishi T; Asada T; Uno M; Kunihiro T; Nakano S; Takasaki M
    J Nucl Med; 2000 Jul; 41(7):1155-62. PubMed ID: 10914904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concerning the distribution of cerebral muscarinic acetylcholine receptors in Alzheimer's disease.
    Zeeberg B
    Arch Neurol; 1991 Nov; 48(11):1117-8. PubMed ID: 1953390
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.
    Nobili F; Vitali P; Canfora M; Girtler N; De Leo C; Mariani G; Pupi A; Rodriguez G
    Clin Neurophysiol; 2002 Aug; 113(8):1241-8. PubMed ID: 12140003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Voxel-based investigations of regional cerebral blood flow abnormalities in Alzheimer's disease using a single-detector SPECT system.
    Duran FL; Zampieri FG; Bottino CC; Buchpiguel CA; Busatto GF
    Clinics (Sao Paulo); 2007 Aug; 62(4):377-84. PubMed ID: 17823698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral muscarinic receptors in primary degenerative dementia as evaluated by SPECT with iodine-123-labeled QNB.
    Weinberger DR; Mann U; Gibson RE; Coppola R; Jones DW; Braun AR; Berman KF; Sunderland T; Reba RC; Chase TN
    Adv Neurol; 1990; 51():147-50. PubMed ID: 2294653
    [No Abstract]   [Full Text] [Related]  

  • 48. Autoradiographic evidence that (R)-3-quinuclidinyl (S)-4-fluoromethylbenzilate ((R,S)-FMeQNB) displays in vivo selectivity for the muscarinic m2 subtype.
    Boulay SF; Sood VK; Rayeq MR; Zeeberg BR; Eckelman WC
    Nucl Med Biol; 1996 Oct; 23(7):889-96. PubMed ID: 8971856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study.
    Versijpt JJ; Dumont F; Van Laere KJ; Decoo D; Santens P; Audenaert K; Achten E; Slegers G; Dierckx RA; Korf J
    Eur Neurol; 2003; 50(1):39-47. PubMed ID: 12824711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A spatial covariance
    Colloby SJ; Field RH; Wyper DJ; O'Brien JT; Taylor JP
    Neurobiol Aging; 2016 Nov; 47():83-90. PubMed ID: 27565302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography.
    Hirao K; Ohnishi T; Matsuda H; Nemoto K; Hirata Y; Yamashita F; Asada T; Iwamoto T
    Nucl Med Commun; 2006 Feb; 27(2):151-6. PubMed ID: 16404228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease.
    O'Brien JT; Eagger S; Syed GM; Sahakian BJ; Levy R
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1182-7. PubMed ID: 1479398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced posterior cingulate binding of I-123 iodo-dexetimide to muscarinic receptors in mild Alzheimer's disease.
    Boundy KL; Barnden LR; Katsifis AG; Rowe CC
    J Clin Neurosci; 2005 May; 12(4):421-5. PubMed ID: 15925773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease.
    Nobuhara K; Halldin C; Hall H; Karlsson P; Farde L; Hiltunen J; McPherson DW; Savonen A; Bergström KA; Pauli S; Swahn CG; Larsson SA; Schnell PO; Sedvall G
    Psychopharmacology (Berl); 2000 Mar; 149(1):45-55. PubMed ID: 10789882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.
    Claus JJ; Dubois EA; Booij J; Habraken J; de Munck JC; van Herk M; Verbeeten B; van Royen EA
    Eur J Nucl Med; 1997 Jun; 24(6):602-8. PubMed ID: 9169565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: correlation with event related potentials.
    Gungor HA; Yildiz A; Aydin F; Gungor F; Boz A; Ozkaynak S
    J Neurol Sci; 2005 Jul; 234(1-2):47-53. PubMed ID: 15950243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT study.
    Sunderland T; Esposito G; Molchan SE; Coppola R; Jones DW; Gorey J; Little JT; Bahro M; Weinberger DR
    Psychopharmacology (Berl); 1995 Sep; 121(2):231-41. PubMed ID: 8545529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [3H]QNB displays in vivo selectivity for the m2 subtype.
    Gitler MS; De la Cruz R; Zeeberg BR; Reba RC
    Life Sci; 1994; 55(19):1493-508. PubMed ID: 7968217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
    Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.